» Articles » PMID: 39294534

Screening and Identification of Susceptibility Genes for Cervical Cancer Via Bioinformatics Analysis and the Construction of an Mitophagy-related Genes Diagnostic Model

Overview
Specialty Oncology
Date 2024 Sep 18
PMID 39294534
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study aims to utilize bioinformatics methods to systematically screen and identify susceptibility genes for cervical cancer, as well as to construct and validate an mitophagy-related genes (MRGs) diagnostic model. The objective is to increase the understanding of the disease's pathogenesis and improve early diagnosis and treatment.

Method: We initially collected a large amount of genomic data, including gene expression profile and single nucleotide polymorphism (SNP) data, from the control group and Cervical cancer (CC) patients. Through bioinformatics analysis, which employs methods such as differential gene expression analysis and pathway enrichment analysis, we identified a set of candidate susceptibility genes associated with cervical cancer.

Results: MRGs were extracted from single-cell RNA sequencing data, and a network graph was constructed on the basis of intercellular interaction data. Furthermore, using machine learning algorithms, we constructed a clinical prognostic model and validated and optimized it via extensive clinical data. Through bioinformatics analysis, we successfully identified a group of genes whose expression significantly differed during the development of CC and revealed the biological pathways in which these genes are involved. Moreover, our constructed clinical prognostic model demonstrated excellent performance in the validation phase, accurately predicting the clinical prognosis of patients.

Conclusion: This study delves into the susceptibility genes of cervical cancer through bioinformatics approaches and successfully builds a reliable clinical prognostic model. This study not only helps uncover potential pathogenic mechanisms of cervical cancer but also provides new directions for early diagnosis and treatment of the disease.

References
1.
Ding Y, Wu X, Yang X . Identification of miRNAs and target genes associated with lymph node metastasis in cervical cancer using bioinformatics analysis. Toxicol Mech Methods. 2023; 33(8):625-635. DOI: 10.1080/15376516.2023.2207644. View

2.
Nguyen T, Do D, Nguyen-Thi M, Hoang-The H, Tran T, Nguyen-Thanh T . Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics. Comput Biol Med. 2022; 149:105996. DOI: 10.1016/j.compbiomed.2022.105996. View

3.
Zang Y, Zhao R, Wang T, Gao Y, Chen L, Liu S . Identification of as a key gene in cervical cancer progression using integrated bioinformatics analysis and experimental validation. Mol Med Rep. 2023; 27(6). DOI: 10.3892/mmr.2023.13002. View

4.
Vidrine J, Sutton S, Wetter D, Shih Y, Ramondetta L, Elting L . Efficacy of a Smoking Cessation Intervention for Survivors of Cervical Intraepithelial Neoplasia or Cervical Cancer: A Randomized Controlled Trial. J Clin Oncol. 2023; 41(15):2779-2788. PMC: 10414739. DOI: 10.1200/JCO.22.01228. View

5.
Lu J, Liu Q, Zhu L, Liu Y, Zhu X, Peng S . Endothelial cell-specific molecule 1 drives cervical cancer progression. Cell Death Dis. 2022; 13(12):1043. PMC: 9755307. DOI: 10.1038/s41419-022-05501-5. View